IL-12 is even more efficient than IL-2 in activation of NK cells [53], and also has a potent anti-tumor activity through augmentation of the cytotoxic activity of NK cells, activation of CD8+ T cells, and the inhibition of angiogenesis [54,55]. Here, IL2 is linked to neoplasm.